Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 38.33 million compared to CNY 22.25 million a year ago. Net loss was CNY 9.72 million compared to CNY 9.06 million a year ago.

Basic loss per share from continuing operations was CNY 0.0798 compared to CNY 0.0744 a year ago. Diluted loss per share from continuing operations was CNY 0.0798 compared to CNY 0.0744 a year ago.